Institute of Social and Preventive Medicine, University of Bern, Switzerland; Research Platform for Pediatric Oncology and Hematology (CANSEARCH Research Platform), Department of Pediatrics, Gynecology, and Obstetrics, University of Geneva, Switzerland.
Institute of Social and Preventive Medicine, University of Bern, Switzerland; Centre universitaire de médecine générale et santé publique (UNISANTÉ), Institute of Social and Preventive Medicine (IUMSP), University of Lausanne, Switzerland.
Eur J Cancer. 2021 Mar;145:71-80. doi: 10.1016/j.ejca.2020.11.042. Epub 2021 Jan 7.
Childhood cancer patients are at increased risk of second primary neoplasms (SPNs). We assessed incidence and risk factors for early SPNs with a focus on cancer predisposition syndromes (CPSs).
This cohort study used data from the Swiss Childhood Cancer Registry. We included patients with first primary neoplasms (FPNs) diagnosed before age 21 years from 1986 to 2015 and identified SPNs occurring before age 21. We calculated standardised incidence ratios (SIRs) and absolute excess risks (AERs) using Swiss population cancer incidence data, and cumulative incidence of SPNs. We calculated hazard ratios (HRs) of risk factors for SPNs using Fine and Gray competing risk regression.
Among 8074 childhood cancer patients, 304 (4%) were diagnosed with a CPS and 94 (1%) developed early SPNs. The incidence of SPNs was more than 10-fold higher in childhood cancer patients than the incidence of neoplasms in the general population (SIR = 10.6, 95% confidence interval [CI]: 8.7-13.1) and the AER was 179/100,000 person-years (CI: 139-219). Cumulative incidence of SPNs 20 years after FPN diagnosis was 23% in patients with CPSs (CI: 12-41%) and 2.7% in those without (CI: 2.0-3.6%). Risk factors for SPNs were CPSs (HR = 7.8, CI: 4.8-12.7), chemotherapy (HR = 2.2, CI: 1.1-4.6), radiotherapy (HR = 1.9, CI = 1.2-2.9), haematopoietic stem cell transplantation (HR = 1.8, CI: 1-3.3), and older age (15-20 years) at FPN diagnosis (HR = 1.9, CI: 1.1-3.2).
CPSs are associated with a high risk of SPNs before age 21 years. Identification of CPSs is important for appropriate cancer surveillance and targeted screening.
儿童癌症患者发生第二原发肿瘤(SPN)的风险增加。我们评估了以癌症易感综合征(CPS)为重点的早期 SPN 的发病率和危险因素。
本队列研究使用了瑞士儿童癌症登记处的数据。我们纳入了 1986 年至 2015 年间诊断为 21 岁以下第一原发肿瘤(FPN)的患者,并确定了 21 岁前发生的 SPN。我们使用瑞士人群癌症发病率数据计算了 SPN 的标准化发病比(SIR)和绝对超额风险(AER),以及 SPN 的累积发病率。我们使用 Fine 和 Gray 竞争风险回归计算了 SPN 危险因素的风险比(HR)。
在 8074 名儿童癌症患者中,有 304 名(4%)被诊断为 CPS,94 名(1%)发生了早期 SPN。儿童癌症患者 SPN 的发病率比一般人群的肿瘤发病率高出 10 多倍(SIR=10.6,95%置信区间[CI]:8.7-13.1),AER 为 179/100000 人年(CI:139-219)。在 FPN 诊断后 20 年,CPS 患者的 SPN 累积发病率为 23%(CI:12-41%),无 CPS 患者的发病率为 2.7%(CI:2.0-3.6%)。SPN 的危险因素包括 CPS(HR=7.8,CI:4.8-12.7)、化疗(HR=2.2,CI:1.1-4.6)、放疗(HR=1.9,CI:1.2-2.9)、造血干细胞移植(HR=1.8,CI:1-3.3)和 FPN 诊断时年龄较大(15-20 岁)(HR=1.9,CI:1.1-3.2)。
CPS 与 21 岁前发生 SPN 的高风险相关。识别 CPS 对于适当的癌症监测和靶向筛查很重要。